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Abstract Three-hybrid assays for the analysis of RNA^protein
interactions in vivo are usually used, due to technical limitations,
only for RNA baits that do not contain runs of four or more
consecutive uridines. The present study provides the ¢rst exam-
ple of a three-hybrid analysis of synthetic and natural uridine-
rich RNA sequences. The use of the three-hybrid assay enabled
us to demonstrate a functional di¡erence between two closely
related proteins, heterogeneous nuclear ribonucleoprotein C1
(hnRNP-C1) and hnRNP-C2. The hnRNP-C2 protein, an alter-
natively spliced variant of hnRNP-C1, contains an additional 13
amino acids between an RNA binding domain (RBD) and a
basic leucine zipper-like motif (bZLM), also implied in RNA
binding. This study shows that (i) for e⁄cient binding of
hnRNP-C1/C2 to RNA, the context of the U-stretch is more
important than the stretch itself ; (ii) both the RBD and the
bZLM bind RNA independently; and (iii) the C2-related 13-
amino acid insert enhances the speci¢city of either the RBD, the
bZLM, or the full-length protein towards its ligand, allowing it
to bind only the most high-a⁄nity sequences while discriminat-
ing against those that do not perfectly match this category. The
three-hybrid system is a powerful tool to work out the functional
signi¢cance of peptide ‘modules’ within RNA binding proteins
generated by alternative splicing. 6 2002 Federation of Euro-
pean Biochemical Societies. Published by Elsevier Science B.V.
All rights reserved.
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1. Introduction
Heterogeneous nuclear ribonucleoproteins (hnRNPs) are
found in the eukaryotic nucleus, associated with heteroge-
neous nuclear RNA (hnRNA) to form higher order struc-
tures. hnRNP-C, together with hnRNP-A and B proteins,
compose the ‘core’ of the 40S hnRNP particle. hnRNP-C
proteins are believed to be involved in pre-mRNA packaging,
spliceosome assembly and in nuclear retention of unspliced
hnRNA (reviewed in [1]). hnRNP-C1 and hnRNP-C2, 41
kDa and 43 kDa, respectively, form a stable heterotetramer,
(C1)3(C2)1. hnRNP-C2, an alternatively spliced variant of
hnRNP-C1, contains an additional 13 amino acids and is ex-
pressed at one-third the level of hnRNP-C1 [2]. The protein
sequence of the hnRNP-C1/C2 proteins, highly conserved
among vertebrates, contains an RNA binding domain
(RBD) and a basic leucine zipper (bZIP)-like motif (bZLM),
both implied in RNA binding [3,4]. The additional 13 amino
acids of the hnRNP-C2 isoform are located between these two
domains.
The RNA binding speci¢cities of hnRNP-C1/C2 proteins
have been studied using various experimental approaches.
The tetramer was characterized as a sequence-independent
RNA chaperonin that is distributed along nascent transcripts
by binding 230 nt of RNA in a high cooperative manner [4,5].
UV-cross-linking experiments characterized hnRNP-C1/C2 as
poly(U) binding proteins, which preferably bind to the pyrim-
idine-rich sequences that precede 3P intron^exon junctions
[6,7], the 5P stem-loop of U2 snRNA [8], the poly(U) stretches
at the 3P end of U4/U6 snRNAs [9], U-rich sequences down-
stream of polyadenylation cleavage sites [10], and to the
AUUUA repeats in the 3P untranslated region (UTR) of sev-
eral labile mRNAs [11,12]. hnRNP-C1/C2 were also found to
be associated with U-rich sequences within 3P UTRs of
mRNAs in correlation to their stabilization [13^15], and
were implicated in enhanced translation of some mRNAs
upon binding to U-stretches within their 5P UTRs [16,17].
In vitro selection/ampli¢cation of RNA oligonucleotides
from a pool of random sequences (the SELEX procedure)
selected oligonucleotides with ¢ve or more contiguous uri-
dines as the high a⁄nity substrate for recombinant hnRNP-
C1 [3]. Competition binding assays under equilibrium condi-
tions using £uorescence spectroscopy and hnRNP-C tetramer
isolated from HeLa cells con¢rmed the high-a⁄nity binding
to one of the SELEX-de¢ned oligonucleotides, termed the
‘winner’ sequence. The latter experiment also showed that
contiguous uridines are not obligatory for generation of
high a⁄nity ligand, suggesting that high a⁄nity may depend
on a unique context or structure of the RNA [18].
All previous studies relied on biochemical in vitro ap-
proaches to analyze the binding properties of hnRNP-C pro-
teins with RNA. Moreover, the possible di¡erences in the
RNA binding properties of hnRNP-C1 and hnRNP-C2 have
never been addressed. In the current study, we analyzed the
binding characteristics of both hnRNP-C1 and hnRNP-C2 to
synthetic and natural RNA sequences using a three-hybrid
system. The three-hybrid assay provides an easy way to study
RNA-protein interactions in the nucleus of a living yeast cell.
Although it does not yield quantitative information that is
comparable to any in vitro biochemical approach, it provides
important information regarding RNA-protein interactions in
vivo. The system is based on binding of a bifunctional hybrid
RNA to each of two hybrid proteins in order to activate the
transcription of a reporter gene, leading to the selection of live
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colonies. Two of such systems were developed independently:
one utilizes RNA polymerase III, whereas the other utilizes
RNA polymerase II for the synthesis of the hybrid RNA
[19,20]. Since RNA polymerase III often terminates at a run
of four or more consecutive uridine residues [21], it imposes a
major problem for the analysis of U-rich RNA baits. There-
fore, we have used in this study the RNA polymerase II-based
system for the analysis of the hnRNP-C1/C2 ligands. We an-
alyzed the binding of hnRNP-C1 and hnRNP-C2 with a syn-
thetic ‘winner’ sequence [18] and with two natural sequences
representing two U-rich domains within the 5P UTR of
PDGF2/c-sis mRNA [16]. This study presents the ¢rst exam-
ple of a successful analysis of RNA-protein interaction to U-
rich sequences using the three-hybrid system. It provides in
vivo evidence for the binding preferences of hnRNP-C pro-
teins towards natural RNA sequences representing di¡erent
regions within a natural mRNA, and it demonstrates for the
¢rst time the functional di¡erences between the two closely
related proteins, hnRNP-C1 and hnRNP-C2.
2. Materials and methods
2.1. Plasmid construction
2.1.1. Hybrid RNA vectors. The sequence of nucleotides 1^227
(‘A’) or 475^797 (‘B’) of the human PDGF2/c-sis 5P UTR was PCR
ampli¢ed using psis4.0 [22] as template and oligonucleotide primers
5P-CCCCACTAGTGGCAACTTCTCCTCC-3P (JB7) and 5P-GCGA-
GCCATGGCTGCTCCGG-3P (OS70) or 5P-GGGTACTAGTGCTG-
CCGTTGC-3P (OS66) and 5P-CAGGCCATGGGTCCGAGGCCGG-
CTA-3P (OS62), respectively. The PCR products were cloned into
blunted MluI site of pPGKRRE [20] between the Rev responsive
element (RRE) and the PGK transcription terminator, to create the
intermediate plasmids pGKRRE-‘A’ and pGKRRE-‘B’, respectively.
The entire transcription unit containing the hybrid RNA between the
PGK promoter and terminator, was excised from the above plasmids
as an XhoI-SalI fragment and cloned into the SalI site of pDBRev-
M10 [20] to create plasmids pDBRevM10-‘A’ and pDBRevM10-‘B’.
The plasmid pDBRevM10-‘winner’ was constructed by inserting a
double-stranded oligonucleotide (prepared by annealing the synthetic
oligonucleotides 5P-CGCGTAGTATTTTTGTGGAGC-3P and 5P-G-
GCCGCTCCACAAAAATACTA-3P) into the MluI^NotI sites of
pRevRX between RRE and PGK terminator. Plasmid pRevRX ex-
presses both ‘hybrid protein 1’ and the transcription unit that drives
the transcription of the hybrid RNA (kindly provided by U. Putz and
D. Kuhl). To generate pRevRX-IRE, a 200 bp EcoRI fragment con-
taining IRE-MS2 was isolated from pIIIA/IRE-MS2^2 [19], blunted,
and cloned into the SmaI site of the pRevRX vector. The resulting
plasmid was digested with SmaI and NotI to remove the MS2 se-
quence, blunted, and self ligated.
2.1.2. ‘Hybrid protein 2’ vectors. Fragments containing the com-
plete coding sequence of hnRNP-C1 (residues 1^290) or hnRNP-C2
(residues 1^303) were generated using pHC12 or pHCC2 templates,
respectively [2], and oligonucleotide primers 5P-CCCCGAGCTCAT-
GGCCAGCAACGTTACC-3P (OS72) and 5P-GATAAGAATTCTA-
AACCCCACTA-3P (OS73). The PCR products were digested with
SacI, ¢lled in, digested with EcoRI and cloned into the SmaI^EcoRI
sites of pACTII (Clontech) to generate plasmids pACTII-C1 and
pACTII-C2, respectively. hnRNP-C1 truncations were generated by
PCR using pHC12 template and the following oligonucleotide prim-
ers: OS72 and 5P-GGGTCGACCATCTCCGCTGCAG-3P (M1-
M104) for C1v1 (residues 1^104); 5P-CCCATGGACTATTATGAT-
AGGATG-3P (Y119-G290) and OS73 for C1v2 (residues 119^290);
OS72 and 5P-GGGTCGACAGACTCCATCTTCAC-3P (M1-S240)
for C1v3 (residues 1^240); Y119-G290 and M1-S240 for C1v4 (resi-
dues 119^240). hnRNP-C2 truncations were generated by PCR using
pHCC2 template and the following oligonucleotide primers: OS72
and 5P-CCCTCGAGCTGAGTAGAG-3P (M1-S119) for C2v1 (resi-
dues 1^119); 5P-CCCCATGGGGTCAGTAAC-3P (G106-G290) and
OS73 for C2v2 (residues 106^303); OS72 and M1-S240 for C2v3
(residues 1^253); G106-G290 and M1-S240 for C2v4 (residues 106^
253). PCR fragments C1v1, C1v3, and C2v1 were digested with SacI,
¢lled-in, digested with SalI and cloned into the SmaI^XhoI sites of
pACTII to generate pACTII-C1v1, pACTII-C1v3, and pACTII-
C2v1, respectively. Fragment C2v1 was digested with SacI, ¢lled-in,
digested with XhoI and cloned into SmaI^XhoI sites of pACTII to
generate plasmid pACTII-C2v1. Fragments C1v2 and C2v2 were
digested with NcoI and EcoRI and cloned into the NcoI^EcoRI sites
of pACTII to generate pACTII-C1v2 and pACTII-C2v2, respectively.
Fragments C1v4 and C2v4 were digested with NcoI and SalI and
cloned into NcoI^XhoI sites of pACTII to generate plasmids pAC-
TII-C1v4 and pACTII-C2v4, respectively. pACTII-IRP [19] express-
ing the GAL4 activating domain fused to the iron responsive element
binding protein (IRP) was kindly provided by M. Wickens.
2.2. Yeast
Yeast strains CG-1945 and Y190 (Clontech) were used. Transform-
ants were grown on YNB plates lacking tryptophan and leucine for
selection of the TRP1 and LEU2 marker genes. Double transformants
forming a stable three-hybrid complex were selected for HIS3 expres-
sion by dropping 10 Wl of a liquid culture grown to OD600 = 0.1 on
YNB plates lacking tryptophan, leucine and histidine and containing
0.5 mM 3-aminotriazole (3-AT) for the CG-1945 strain or 100 mM
3-AT for the Y190 strain. Cells were allowed to grow for 7^10 days
at 30‡C.
2.3. Colony color assay (LacZ expression)
Logarithmically growing cells (2 Wl, OD600 0.3) were dropped onto
a nitrocellulose ¢lter (diameter 82 mm, BA85; Schleicher and Schuell)
placed on a YNB plate lacking tryptophan and leucine. Following 48 h
at 30‡C, ¢lters were removed and incubated overnight in 380‡C.
The ¢lters were then thawed on 3 mm paper at room temperature for
1 min and then placed on No. 576 paper (Schleicher and Schuell) that
had been soaked with Z bu¡er (Clontech) containing 0.03% Xgal (5-
bromo-4-chloro-3-indolyl-L-D-galactoside). Blue color was developed
during 2^5 h incubation at 30‡C.
3. Results
3.1. hnRNP-C1 interacts with the central part of PDGF2/c-sis
mRNA leader, but not with another U-rich sequence within
the mRNA
Using UV-cross-linking experiments, we previously identi-
¢ed the central region of the PDGF2/c-sis 5P UTR as a high
a⁄nity site for hnRNP-C1/C2 binding. This region, spanning
nucleotides 475^797 of the PDGF2/c-sis mRNA (termed se-
quence ‘B’ throughout the current study), contains a stretch of
uridines in a context similar to that of the ‘winner’ sequence, a
synthetic sequence previously selected as a high-a⁄nity ligand
for hnRNP-C proteins [3,18]. In contrast, another U-rich re-
gion within the PDGF2/c-sis 5P UTR, spanning nucleotides 1^
227 (termed sequence ‘A’ throughout the current study), did
not show a signi¢cant binding activity towards hnRNP-C1/C2
proteins as judged by the UV-cross-linking assay [16].
To con¢rm the speci¢c binding of hnRNP-C1 to sequence
‘B’ in vivo, we employed the yeast three-hybrid system in
which ‘hybrid protein 1’ (harboring the DNA binding domain
of GAL4) is brought to a close proximity with ‘hybrid protein
2’ (harboring the GAL4 activation domain) via an interaction
of both hybrid proteins with a hybrid RNA. Upon the for-
mation of a stable three-hybrid complex, the transcription of
the HIS3 and lacZ genes is activated [20]. In this system, the
hybrid RNA is composed of the Rev responsive element
(RRE) fused to the RNA sequence of interest, e.g. the bait.
Its synthesis is carried out by RNA polymerase II, which can
e⁄ciently transcribe an RNA with uridine stretches. Since
hnRNP-C1 over-expression in yeast was found to be lethal
[23], we have used a single copy plasmid for the expression
of ‘hybrid protein 2’ to lower its toxicity to a level that per-
mitted selection of colonies that express HIS3 due to the for-
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mation of a stable three-hybrid complex. LacZ expression was
demonstrated by a qualitative colony color assay since it was
below the detection limits of a quantitative liquid assay.
As illustrated in Fig. 1, sequence ‘A’ or ‘B’ within the 5P
UTR of PDGF2/c-sis or the ‘winner’ sequence [18] were fused
to RRE to create the hybrid RNAs. ‘Hybrid protein 1’ har-
bors a mutated Rev protein (RevM10) that binds RRE with-
out mediating its nuclear export. Due to the RevM10 compo-
nent, the three-hybrid complex is retained in the nucleus and
thus can activate the transcription of the reporter genes. ‘Hy-
brid protein 2’ was designed to carry the RNA binding pro-
tein of interest, e.g. hnRNP-C1 or hnRNP-C2 (see Fig. 1)
being tested for its ability to bind to the bait. As a positive
control for the three-hybrid interaction, the IRP and its cog-
nate RNA, the iron responsive element (IRE), were used as a
‘hybrid protein 2’/hybrid RNA pair. Combinations of the
three-hybrid components were introduced into the yeast
Y190 strain followed by selection for growth on histidine-
lacking media supplemented with 3-AT, which further in-
creases the selectivity for the HIS3 marker. Colonies formed
due to su⁄cient activation of HIS3 transcription were further
tested for activation of LACZ expression. E¡ective growth on
selective media and formation of a blue color is indicative of
an RNA-protein interaction. Fig. 2A demonstrates the e⁄-
cient interaction of IRP with the ‘IRE’ sequence but not
with sequence ‘A’ nor with sequence ‘B’. Fig. 2A also dem-
onstrates the e⁄cient interaction of hnRNP-C1 with the ‘win-
ner’ sequence and with sequence ‘B’ which contains a stretch
similar to the ‘winner’, but not with sequence ‘A’ which also
contains a stretch of uridines (see Fig. 1). RT-PCR analysis
con¢rmed the e⁄cient expression of ‘A’ and ‘B’ sequences. In
fact, as demonstrated in Fig. 2B, sequence ‘A’ was better ex-
pressed than sequence ‘B’ and yet a more stable three-hybrid
complex was formed with sequence ‘B’. This data clearly
shows that for e⁄cient binding to hnRNP-C1, the context
of the U-stretch is more important than the stretch itself,
demonstrating for the ¢rst time the sequence speci¢city of
hnRNP-C1 binding in vivo.
Fig. 1. Schematic presentation of the three-hybrid system. The system is composed of three hybrid components as detailed by Putz et al. [20].
Hybrid protein 2 is composed of complete or truncated hnRNP-C1 or hnRNP-C2 coding sequences (see Fig. 4) fused to the GAL4 activation
domain. The hybrid RNA is composed of the RRE fused to nucleotides 1^227 (sequence ‘A’) or 475^797 (sequence ‘B’) of the human PDGF2/
c-sis 5P UTR, respectively, or to the synthetic oligomer selected as the ‘winner’ sequence for hnRNP-C binding [3,18]. U-rich regions are under-
lined. Sequence similarities are highlighted by red bold letters.
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3.2. hnRNP-C1 and hnRNP-C2 di¡er in their RNA binding
characteristics
hnRNP-C2, an alternatively spliced variant of hnRNP-C1,
contains an additional 13 amino acids between the RNA bind-
ing domains RBD and bZLM [3]. Since the 13-amino acid
insertion within hnRNP-C2 does not interfere with the pri-
mary sequence of either of the RNA binding motifs, the RNA
binding speci¢cities of hnRNP-C1 and hnRNP-C2 were con-
sidered to be identical and have never been compared. Here,
we used the three-hybrid system to test the binding of both
hnRNP-C1 and hnRNP-C2 proteins to the di¡erent RNA
baits. Fig. 3A demonstrates that hnRNP-C2 was able to
form a stable complex with the ‘winner’ sequence, as judged
by the growth on histidine-lacking plates and by LACZ ex-
pression in strain Y190. However, in contrast to hnRNP-C1,
hnRNP-C2 was not able to e⁄ciently bind sequence ‘B’ (com-
pare Fig. 2A to Fig. 3A). Western analysis con¢rmed the
e⁄cient expression of both hnRNP-C1 and hnRNP-C2 (Fig.
3B). Note that although hnRNP-C proteins are toxic for yeast
cells, they are expressed under selective pressure that selects
for three-hybrid complex formation. The negative e¡ect of the
13-amino acid insert in hnRNP-C2 on its binding to sequence
‘B’ was established using an additional yeast strain, CG-1945
(Fig. 3A). LacZ expression in this strain was below detection
limits due to the weak CYC1 minimal promoter. However, by
assaying for HIS3 expression we were able to con¢rm the
observation that the interaction of hnRNP-C2 with sequence
‘B’ was signi¢cantly less e⁄cient than the interaction of
hnRNP-C1 with sequence ‘B’. This data suggests that the
hnRNP-C2-related small peptide insertion enhances the spe-
ci¢city of the protein towards its ligand, allowing it to bind
only high-a⁄nity sequences (such as the ‘winner’) and to dis-
criminate more stringently against sequences that do not per-
fectly match this category (such as sequence ‘B’ or ‘A’).
3.3. The 13-amino acid insertion in hnRNP-C2 a¡ects the RNA
binding characteristics of both the RBD and the bZLM
domains
The three-hybrid system was further used to test the ability
of hnRNP-C1 or hnRNP-C2 truncated forms to interact with
the di¡erent RNA baits. The RNA binding capacities of the
RBD alone, the bZLM alone or both of them together were
checked. Two versions of each truncation, e.g. with or without
the hnRNP-C2-related 13-amino acid insertion, were analyzed
in order to determine whether the e¡ect of the small peptide
on RNA binding was speci¢c to one or both of the RNA
binding domains. The expression of all the truncated proteins
was con¢rmed by Western analysis (not shown). Fig. 4, show-
ing the three-hybrid assay, demonstrates that both the RBD
Fig. 2. hnRNP-C1 forms a stable complex with sequence ‘B’ but
not with sequence ‘A’. A: pACTII-IRP or pACTII-C1 expressing
IRP or hnRNP-C1 as part of ‘hybrid protein 2’ were co-transfected
into Y190 yeast strain together with pRevRX-IRE, pDBRevM10-
‘A’, pDBRevM10-‘B’, or pDBRevM10-‘winner’ expressing the hy-
brid RNA bearing the di¡erent baits as indicated, in addition to
‘hybrid protein 1’. Colonies were selected for HIS3 expression and
assayed for LACZ expression. B: Total RNA was extracted from
colonies expressing pACTII-C1 and pDBRevM10-‘A’/pDBRevM10-
‘B’ subjected to RT-PCR using oligonucleotide primers that are de-
scribed in Section 2 and separated on 2% agarose gel electrophore-
sis. 1,2: 25 PCR cycles without RT; 3,4: RT followed by 20 PCR
cycles; 5,6: RT followed by 25 PCR cycles. 1,3,5: ampli¢cation of
sequence ‘B’; 2,4,6: ampli¢cation of sequence ‘A’.
Fig. 3. hnRNP-C1 and hnRNP-C2 di¡er in their RNA binding
characteristics. A: pACTII-C1 or pACTII-C2 expressing hnRNP-C1
or hnRNP-C2 as part of ‘hybrid protein 2’, were co-transfected into
Y190 or CG-1945 yeast strains together with pDBRevM10-‘A’,
pDBRevM10-‘B’, or pDBRevM10-‘winner’ expressing the di¡erent
baits as indicated, in addition to ‘hybrid protein 1’. Colonies were
selected for HIS3 expression and assayed for LACZ expression. B:
50 Wg protein extracted from Y190 strain co-transfected with
pDBRevM10-‘winner’ and pACTII-C1 (lanes 1,2) or pDBRevM10-
‘winner’ and pACTII-C2 (lanes 3,4), not selected (lanes 2,3) or se-
lected (lanes 1,4) for survival in 100 mM 3AT, were analyzed by
10% SDS^PAGE followed by Western analysis using antibodies spe-
ci¢c for HA epitope.
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and the bZLM were able to bind RNA independently, with
e⁄ciencies similar to the full-length form of the protein. In-
terestingly, the presence of the hnRNP-C2-related 13-amino
acid stretch impaired the ability of either the RBD or the
bZLM to bind the PDGF2/c-sis mRNA-derived sequences,
but did not a¡ect their ability to bind to the ‘winner’ se-
quence. This data demonstrates that the hnRNP-C2-related
small peptide enhances the RNA binding speci¢city of either
the RBD or the bZLM domains.
4. Discussion
An important question concerning hnRNP-C proteins, cen-
ters on their RNA binding characteristics, e.g. their binding
preferences and the elements conferring RNA binding specif-
icity. High-a⁄nity binding sites for puri¢ed recombinant
hnRNP-C1 have been identi¢ed by Gorlach et al. [3] using
the SELEX procedure that revealed 28 oligonucleotides, each
harboring one or more groups of ¢ve or more contiguous
uridines. Accordingly, preference for U-rich sequences has
been documented by numerous UV-cross-linking studies [6^
17]. However, Soltaninassab et al. [18] have shown that
although native hnRNP-C proteins puri¢ed from HeLa cells
possess enhanced a⁄nity towards one of the SELEX-identi-
¢ed oligonucleotide, termed the ‘winner’ sequence, they pos-
sess no enhanced a⁄nity to other U-rich oligonucleotides. The
present study is consistent with the latter observation. It
clearly demonstrates that under physiological conditions,
e.g. in the nucleus of a living yeast cell, hnRNP-C1 e⁄ciently
binds the synthetic ‘winner’ sequence but possesses a clear
preference towards one of the two natural U-stretch-contain-
ing sequences. Since sequence ‘A’, which contains a stretch of
¢ve contiguous uridines, did not mediate the formation of a
three-hybrid complex, it seems that contiguous uridines do
not alone de¢ne a high a⁄nity substrate. The high similarity
between sequence ‘B’ and the ‘winner’ and the ability of se-
quence ‘B’ to mediate the formation of a three-hybrid com-
plex suggest that unique structures with steric nucleotide po-
sitioning may a¡ect hnRNP-C protein interactions with
natural RNA molecules in vivo, in agreement with a previous
study [18]. How does this observation ¢t with the description
of hnRNP-C1/C2 tetramer as an RNA chaperonin that binds
230 nt along the RNA in a sequence-independent, highly co-
operative manner [4]? One possibility may be that high-a⁄n-
Fig. 4. The e¡ect of the hnRNP-C2-related small peptide on RNA binding by the RBD and the bZLM. A: Schematic presentation of the
hnRNP-C1/C2 truncations detailed in Section 2. B: Each pACTII plasmid expressing the indicated truncated protein as part of ‘hybrid protein
2’ was co-transfected into Y190 yeast strain together with pDBRevM10 plasmid expressing the di¡erent baits as indicated, in addition to ‘hy-
brid protein 1’. Colonies were selected for HIS3 expression and assayed for LACZ expression.
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ity sequences along the long hnRNA molecule serve as nucle-
ation sites for initial hnRNP-C binding followed by further
binding along the length of the nascent transcripts.
This study demonstrates that the 13-amino acid insert that
distinguishes hnRNP-C2 from hnRNP-C1 directly in£uences
RNA binding. The hnRNP-C2-associated insertion, beginning
after Gly106, negatively a¡ected the binding a⁄nity to se-
quence ‘B’, whereas no signi¢cant in£uence on binding to
the ‘winner’ sequence was observed. Interestingly, Gorlach
et al. [3] previously reported that the 10 amino acids immedi-
ately preceding the COOH-terminal to the RBD motif (amino
acids 95^104) prevented the minimal RBD from binding non-
speci¢c RNA sequences. Here we show that the additional 13
residues further a¡ect RNA binding by enhancing the discrim-
ination ability against sequences that do not belong to the
group of the highest-a⁄nity ligands. What is the physiological
signi¢cance of hnRNP-C2? It is an open question whether the
RNA binding performance by C13C2 tetramer di¡ers from
that of C14 tetramer. It is possible that the C13C2 formula
constitutes the best design to ¢t a physiological function such
as binding to certain high-a⁄nity sequences followed by a
more uniform, less discriminative, high-cooperative binding
along nascent transcripts. This concept awaits experimental
veri¢cation. Interestingly, a remarkably similar example re-
lates to two additional hnRNP core proteins, hnRNP-A2
and hnRNP-B1, that di¡er by only a 12-amino acid insert
in hnRNP-B1 [2]. It is an open question whether the B1-re-
lated small peptide has a direct e¡ect on RNA binding.
The RNA binding activity of hnRNP-C proteins is con-
ferred by its canonical RBD comprising the amino-terminal
94 amino acids [3,24,25], and by a bZLM motif comprising
residues 140^207 of hnRNP-C1 or 153^220 of hnRNP-C2
[4,26,23]. The data regarding RNA binding by both domains
has been accumulated via a series of in vitro studies, some of
which were performed under physiological conditions. The in
vivo data obtained here from the yeast three-hybrid system
demonstrate the ability of each of the two domains to mediate
the formation of a stable three-hybrid complex, con¢rming
the ability of the RBD and of the bZLM to independently
bind RNA. The current study provides interesting new infor-
mation regarding the ability of the C2-related 13 amino acids
to a¡ect the RNA binding characteristics of both the RBD
and the bZLM. In the presence of the small peptide, both
domains were more competent in distinguishing between the
various RNA sequences and picked only high-a⁄nity ligands.
The three-hybrid system is a powerful tool to work out the
functional signi¢cance of peptide ‘modules‘ within RNA bind-
ing proteins generated by alternative splicing.
Acknowledgements: We thank U. Putz and D. Kuhl for the three-
hybrid system that includes the pPGKRRE, pDBRevM10, pACTII,
pRevRX plasmids and the CG1945 yeast strain, M. Wickens for
pIIIA/IRE-MS2-2 and pACTII-IRP plasmids, and G. Dreyfuss for
pHC12 and pHCC2 plasmids. We thank Debbie Silvera for comments
on the manuscript. This work was supported by Grant 4367 from the
Chief Scientist’s O⁄ce of Ministry of Health, Israel, and by a grant
from the Israel Cancer Association. N. Koloteva-Levine’s fellowship
was supported by the Israel Cancer Research Fund.
References
[1] Dreyfuss, G., Matunis, M.J., Pinol-Roma, S. and Burd, C.G.
(1993) Annu. Rev. Biochem. 62, 289^321.
[2] Burd, C.G., Swanson, M.S., Gorlach, M. and Dreyfuss, G.
(1989) Proc. Natl. Acad. Sci. USA 86, 9788^9792.
[3] Gorlach, M., Burd, C. and Dreyfuss, G. (1994) J. Biol. Chem.
269, 23074^23078.
[4] McAfee, J., Shahied-Milam, L., Soltaninassab, S. and LeStour-
geon, W. (1996) RNA 2, 1139^1152.
[5] Huang, M., Rech, J.E., Northington, S.J., Flicker, P.F., Mayeda,
A., Krainer, A.R. and LeStourgeon, W.M. (1994) Mol. Cell.
Biol. 14, 518^533.
[6] Swanson, A. and Dreyfuss, G. (1988) Mol. Cell. Biol. 8, 2237^
2241.
[7] Swanson, M.S. and Dreyfuss, G. (1988) EMBO J. 7, 3519^3529.
[8] Tetsamani, J. and Pederson, T. (1996) J. Biol. Chem. 271, 24922^
24926.
[9] Forne, T., Rossi, F., Labourier, E., Antoine, E., Cathala, G.,
Brunel, C. and Tazi, J. (1995) J. Biol. Chem. 270, 16476^16481.
[10] Wilusz, J., Feig, D.I. and Shenk, T. (1998) Mol. Cell. Biol. 8,
4477^4483.
[11] Hamilton, B.J., Nagy, E., Malter, J.S., Arrick, B.A. and Rigby,
W.F. (1993) J. Biol. Chem. 268, 8881^8887.
[12] Sokolowski, M. and Schwartz, S. (2001) Virus Res. 73, 163^175.
[13] Zaidi, S.H.E. and Malter, J.S. (1995) J. Biol. Chem. 270, 17292^
17298.
[14] Rajagopalan, L.E., Westmark, C.J., Jarzembowski, J.A. and
Malter, J.S. (1998) Nucleic Acids Res. 26, 3418^3423.
[15] Nanbu, R., Montero, L., d’Oraazio, D. and Nagamine, Y. (1997)
Eur. J. Biochem. 247, 169^174.
[16] Sella, O., Gerlitz, G., Le, S.Y. and Elroy-Stein, O. (1999) Mol.
Cell. Biol. 19, 5429^5440.
[17] Millard, S.S., Vidal, A., Markus, M. and Ko¡, A. (2000) Mol.
Cell. Biol. 20, 5947^5959.
[18] Soltaninassab, S.R., McAfee, J.G., Shahied-Milam, L. and Le-
Stourgeon, W.M. (1998) Nucleic Acids Res. 26, 3410^3417.
[19] SenGupta, D.J., Zhang, B., Kraemer, B., Pochart, P., Fields, S.
and Wickens, M. (1996) Proc. Natl. Acad. Sci. USA 93, 8496^
8501.
[20] Putz, U., Skehel, P. and Kuhl, D. (1996) Nucleic Acids Res. 24,
4838^4840.
[21] Geiduschek, E.P. and Tocchini-Valentini, G.P. (1988) Annu.
Rev. Biochem. 57, 873^914.
[22] Rao, C.D., Pech, M., Robbins, K.C. and Aaronson, S.A. (1988)
Mol. Cell. Biol. 8, 284^292.
[23] Tan, J., Kajiwara, Y., Shahied, L., Li, J., McAfee, J. and Le-
Stourgeon, W.M. (2001) J. Mol. Biol. 305, 829^838.
[24] Gorlach, M., Wittekind, M., Beckman, R., Mueller, L. and Drey-
fuss, G. (1992) EMBO J. 11, 3289^3295.
[25] Wan, L., Kim, J.K., Pollard, V. and Greyfuss, G. (2001) J. Biol.
Chem. 276, 7681^7688.
[26] Shahied-Milam, L., Soltaninassab, S., Iyer, G. and LeStourgeon,
W.M. (1998) J. Biol. Chem. 273, 21359^21367.
FEBS 26243 8-7-02 Cyaan Magenta Geel Zwart
N. Koloteva-Levine et al./FEBS Letters 523 (2002) 73^7878
